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Nodal Metastasis of Human Gastric Carcinoma 
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= Abstract = Reduced expression of nm23 gene or protein has been known to be 
related with nodal metastasis in a variety of malignant tumors of the breast, lung, 
liwr, prostate, ovary and stomach. To elucidate a possible prognostic factor, we 
studied 42 cases of gastric adenocarcinomas for the expression of nm23 protein 
using immunohistochemical methods and compared with the known prognostic 
parameters. The nm23 protein was intensely stained in the cytoplasm and/or the 
nucleus of carcinoma cells in 9 cases(21.4%). The nm23 protein expression of the 
non-metastatic group(46.7%) was higher than that of the nodal metastasis group(7. 
4%). Perigastric lymph node metastases(p(0.001) were more frequently found in the 
nm23 protein negatiw group(75.8%) than in the nm23 positive group(22.2%). There 
was no significant correlation between nm23 protein expression and other para- 
meters such as patient age, sex, WHO grade, Lauren classification, depth of 
invasion, location of tumor and size. The results suggest that nm23 protein expr- 
ession plays a role in suppression of nodal metastasis in the gastric adenocarcinoma. 
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INTRODUCTION 
The nm23 gene has been reported to be a met- 
astasls suppressor gene based on the experiment 
uslng murlne K-1735 melanoma cell lhnes w ~ t h  low 
and h ~ g h  metastatlc potentla1 (Steeg et al. 
1988a&b). The transfect~on of nm23 gene Into a 
h~ghly metastatlc murlne melanoma cell l ~ne  res- 
ulted In the reduction of metastatlc potentlal and 
primary tumor formation wlthout differences In In- 
trlnslc tumor cell growth (Leone et a/  1991) The 
gene 1s located In the long arm of chromosome 
17 (Varesco et a1 1992 Stephenson et a1 1993) 
and 1s known to be related wlth nucleoslde dtp- 
hosphate (NDP) klnase (Kimura et a /  1988231 990 
Llotta & Steeg 1990 G~lles et a1 1991 Negat~ve 
correlations of nm23 expression wlth human can- 
cers from the breast (Bevllacqua et al 1989 Bar- 
nes et a1 1991 Hlrayama et a1 1991 Royds et a1 
1993 Yamashlta et a1 1993 Slmpson et a1 1993) 
ovary (Foulkes et a1 1993 Mandal et a1 1994) 
prostate ( K o n ~ s h ~  et a1 1993 Brewster et a1 1994 
lgawa et a1 1994) pancreas(Nakamor1 et a1 
1993) colon and rectum (Leone et a1 1991 Cohn 
et a1 1991 Myeroff et a1 1993 Yamaguch~ et a/  
1993 Baflco et a1 1993) lung (Leone et a1 1991 
Engel et a /  1993) thyroid (Aral et a1 1993 Zou et 
a1 1993; Farley et a / .  1993) and stomach (Nak- 
ayama et a1 1993; Kodera et al. 1994) have been 
reported. 
Because gastric cancer still remains the leadlng 
cause of cancer death in Korea, i t  would be of 
great significance i f  something other than the 
known cl~nical or histopathologic parameters 
could be predictable for the metastasis and prog- 
nosis of gastric cancer. We studied the nm23 pro- 
tein expression of surgically resected gastric can- 
cer t~ssues, with the hope that the ~mmunohistoc- 
hemical expression of nm23 protein might be one 
of such predlctlve factors. 
MATERIAL AND METHOD 
1. Material 
Tissues were obtained from 42 surgically res- 
ected stomachs in the Department of Surgery. 
Seoul National Univers~ty Hospital during the per- 
iod from January 1990 to December 1992, with 
age and sex matching 
2. Method 
Samples were f~xed wlth 10% neutrally buffered 
formalin for 24 hours processed routinely, and 
embedded In paraff in Paraffin-embedded tlssues 
were cut Into 5 um-thlck sectlons and processed 
~mmunohistochem~cally The tlssues were deparaf- 
flnlzed treated by 0 3% H202 for 15 minutes and 
blocklng serum for 30 mlnutes Then, we used prl- 
mary antlbody NCL-nm23 (Novocastra Laborat- 
ories Ltd 1 wlth the dllutlon of  1 200 at room tem- 
perature for 2 hours Consequently, av~din-biottn 
peroxldase complex method was performed using 
an LSAB ktt (DAKO) Flnally, the tissues were stain- 
ed with dlaminobenzid~ne and were counter-stain- 
ed wtth hematoxyltn 
For the stattstical analysts. we used F~shers  
exact test or Chi-square test using the PC-SAS 
program 6 04 version 
RESULTS 
The nm23 proteln was intensely stalned In the 
cytoplasm and/or the nucleus of carcinoma cells 
In 9 (21 4'0) out of 42 cases(Ftg 1 )  Although 
some cases showed weak stain~ng, we discarded 
the cases that showed stalnabillty either weaker 
than the adjacent non-cancerous mucosa or het- 
erogeneous statnlng Some cases showed more 
intense staining In the well differentiated area and 
weaker staining In the poorly differentiated area 
Furthermore, the deeper por t~on o f  the tumor 
showed the weaker staining in cases The nm23 
protein expression was definite in 7 of 15 cases 
(46 7 % )  of the non-metastatic group, while it  was 
definite in 2 of 27 cases (7 4%)  of the nodal met- 
astasis group (Fig 2) Thus the positive ratio was 
much higher in the non-metastatic group, and ~t 
was statistically significant by a p value less than 
001 We tried to compare this finding to other 
data related to the prognosis There was no slg- 
nlflcant correlation between nm23 protein ex- 
pression and other parameters such as patient 
age sex, WHO grade, Lauren classification, depth 
of invasion, locat~on of tumor and size (Table 1 )  
although the Lauren's diffuse type and larger tum- 
o r (>5cm)  were more frequently found In the 
nm23 negative group than in the nm23 positive 
group (Fig 3) Only perigastrlc lymph node met- 
asis was significantly associated with nm23 pro- 
tein expression (p< 0 001 ) 
DISCUSSION 
The actual mechanism by whlch nm23 gene or 
product affects invasive or metastatic potential 
still remains unknown Because of the homology 
between the nucleoside diphosphate (NDP) kinase 
and the role of NDP kinase in cytoskeleton status 
and cell to cell commun~cation (Nickerson & Wells 
1984 Gilles et a1 1991 ) ,  ~t could be pred~cted that 
the nm23 takes part In cell adhesion or migration, 
namely invasion or metastas~s (Kodera et a1 
1994) However, controversies are still present, 
and additional studies are mandatory 
The expression of nm23 gene has been known 
to be Inversely correlated with metastatic potential 
in various human cancers as well as gastrlc can- 
cer In gastric cancer, it has been reported that 
nm23 gene expression was higher in primary can- 
cer t~ssue than in matched mucosa (Nakayama et 
a1 1993) Furthermore, it has been suggested that 
Fig. 1. Photomicrographs of the nm23 pos~ t~ve  ( A )  and negat~ve (B) gastr~c cancer cells 
NM23(+) NM23(-) 
.metastasis Cdi f fuse .size>5cm 
Fig. 3. The rates of lymph node metastas~s. Laur- 
en's diffuse type and large tumor size (>5 
cm) accord~ng to nm23 protein expression 
-. The nm23 protein expression rate accord- 
ing to lymph node metastasis 
Table 1. Relationship between nm23 protein expression and clinicopathologic parameters in gastric 
adenocarcinoma 
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NS not s~gnif~cant 
nm23 reactivity p value 
negative positive 
the down-regulation of nm23 gene mlght have a 
role In metastas~s and lnvaslon In gastrlc cancer. 
poss~bly leadlng to a poor prognosls(Kodera et 
a1 1994) W~th regard to the loss of heterozygos- 
~ t y  ~t was not only rare or hardly found but was 
also not related wlth cltnlco-pathologic features 
(Nakayama et a1 1993 Kim et a1 1993) The cur- 
rent study demonstrates that reduced expresslon 
of nm23 proteln In gastrlc adenocarclnoma would 
be related w ~ t h  lymph node metastasls Some fac- 
tors such as Lauren s dlffuse type and large tum- 
or size were also related wlth the down-regu- 
latlon of nm23 proteln expression although there 
was no stat~st~cal s~gnlf~cance There has been 
controversy as to whether the dlfferentlat~on of 
gastrlc adenocarc~noma IS associated w ~ t h  nm23 
expresslon (Kodera et a1 1993 Nakayarr~a et a1 
1994) The actlon mechanrsm of nm23 In cancer 
might be explained by a bimodal pattern. First, it 
might act as a suppressor of invasion in mam- 
mary ductal carcinoma In situ (Simpson et a/. 
1994). Second, i t  mlght act as a well-known sup- 
pressor of lymph node metastasis. Gastric carcin- 
ogenesis has been explained by two pathways, de 
novo or by way of colonic metaplasia. In that sen- 
se, we presume that the genetic events of gastric 
carcinomas with reference to Lauren's classifi- 
cation would show discrepancy with each other. 
Our study has the limitations of a small number 
of cases and short follow-up period. Therefore, 
we are preparing more reliable data with a larger 
number of cases with longer follow-up period. 
In Korea, studies related to the metastatic po- 
tentlal of human cancer and nm23 expression 
have only been performed in breast carcinomas, 
especially using the immunoh~stochemical method 
(Song et a / .  submitted). Although the loss of het- 
erozygosity has been studied in gastric adenocar- 
cinoma, the result was not contributory(Kim et a/. 
1993). We hope that additional extensive studies 
elucidating the role of nm23 in the metastasis of 
various human cancers will be performed In the 
near future. 
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